Skip to main content

Market Overview

New $150 Million Injective Ecosystem Fund Supports Cosmos, DeFi Adoption

Share:
New $150 Million Injective Ecosystem Fund Supports Cosmos, DeFi Adoption

Layer 1 blockchain Injective launched a $150 million ecosystem fund to “accelerate developer adoption” for optimized financial applications.

What Happened: Injective’s new fund is supported by notable Web3 and traditional finance organizations which the company said represented the largest consortium in the Cosmos ecosystem. Partners include Pantera Capital, Kucoin Ventures, Jump Crypto, IDG Capital, Gate Labs, Delphi Labs, Flow Traders and Kraken Ventures.

Injective’s CEO and co-founder Eric Chen explained the intention of the fund to TechCrunch in an interview:

“We’ve seen a lot of ecosystem funds in the past do various things, but there isn’t really an established ecosystem fund for Injective and Cosmos as a whole. We call it a venture consortium because they can get investments from there or direct institutions.”

Why It Matters: The Injective Ecosystem Fund provides funding to support builders with a range of specialties, such as interoperability, DeFi, trading, PoS infrastructure and scaling solutions.

Chen added the fund would start with early-stage projects and mark its launch with a hackathon to attract talent and investors and create more opportunities for participants.

Developers were asked to submit an application that details the concept, team and development plan which would be reviewed by the Venture Group.

Photo: Arek Socha from Pixabay.

 

Related Articles

View Comments and Join the Discussion!

Posted-In: Blockchain Cosmos DeFi Eric Chen InjectiveCryptocurrency News Markets Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com